Martin Suchan

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Genomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2026
The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth.

|Jun 12, 2024
Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates.

Franziska Lang, Patrick Sorn, Martin Suchan

|Mar 29, 2023
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids.

Vinzenz Särchen, Lisa Marie Reindl, Sara Wiedemann

|Mar 16, 2023
A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination.

Matthias Birtel, Ralf-Holger Voss, Katharina Reinhard

|Apr 05, 2022
Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens.

David Weber, Jonas Ibn-Salem, Patrick Sorn

|Nov 23, 2020
Integrative analysis of structural variations using short-reads and linked-reads yields highly specific and sensitive predictions.

Riccha Sethi, Julia Becker, Jos de Graaf

Pageof 1

Frequent Collaborators

3 joint publications

Barbara Schrörs

2 joint publications

David Weber

2 joint publications

Jonas Ibn-Salem

2 joint publications

Ugur Sahin